TRPV3

Chr 17AD

transient receptor potential cation channel subfamily V member 3

Also known as: FNEPPK2, OLMS, OLMS1, VRL3

This gene product belongs to a family of nonselective cation channels that function in a variety of processes, including temperature sensation and vasoregulation. The thermosensitive members of this family are expressed in subsets of sensory neurons that terminate in the skin, and are activated at distinct physiological temperatures. This channel is activated at temperatures between 22 and 40 degrees C. This gene lies in close proximity to another family member gene on chromosome 17, and the two encoded proteins are thought to associate with each other to form heteromeric channels. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 1.152 OMIM phenotypes
Clinical SummaryTRPV3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
10 unique Pathogenic / Likely Pathogenic· 232 VUS of 489 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.15LOEUF
pLI 0.000
Z-score 0.82
OE 0.86 (0.651.15)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.17Z-score
OE missense 0.98 (0.911.06)
467 obs / 477.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.86 (0.651.15)
00.351.4
Missense OE?0.98 (0.911.06)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 33 / 38.5Missense obs/exp: 467 / 477.5Syn Z: -0.31
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedTRPV3-related palmoplantar keratoderma, nonepidermolytic, focalOTHERAD
strongTRPV3-related Olmsted syndromeOTHERAD

This gene — mechanism propensity

DN
0.6259th %ile
GOF
0.77top 25%
LOF
0.3454th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation · 100% of P/LP are missense
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFMutations in TRPV3 (Transient receptor potential vanilloid-3) gene have recently been identified as a cause of autosomal dominant (gain-of-function mutations) or recessive OS.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 25886873

ClinVar Variant Classifications

489 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic1
VUS232
Likely Benign72
Benign149
Conflicting19
9
Pathogenic
1
Likely Pathogenic
232
VUS
72
Likely Benign
149
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
9
0
0
9
Likely Pathogenic
0
1
0
0
1
VUS
4
165
62
1
232
Likely Benign
0
12
22
38
72
Benign
1
13
116
19
149
Conflicting
19
Total520020058482

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

41 pathogenic / likely-pathogenic (of 75) ClinVar copy-number / structural variants overlap TRPV3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TRPV3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →